Oral Antibiotics for Pseudomonas: What Are the Options?

Pseudomonas is a bacterium that shrugs off most of the antibiotics doctors can prescribe as pills, so the menu of oral options is short. In practice the choice usually comes down to one family of drugs, with ciprofloxacin as the long-standing workhorse.1PubMed Central. A Review of the Clinical Utilization of Oral Antibacterial Therapy in the Treatment of Bone Infections in Adults Even that family can lose its grip during a course, which is why how the pills are taken matters almost as much as which one is chosen.

The Pills That Work Against Pseudomonas

Ciprofloxacin, levofloxacin and delafloxacin belong to one drug family, the fluoroquinolones. They kill bacteria rather than just slowing them down, by blocking an enzyme the bacteria need to copy and repair their DNA. Ciprofloxacin has a specific approved use against Pseudomonas.2PubMed Central. A Review of the Clinical Utilization of Oral Antibacterial Therapy in the Treatment of Bone Infections in Adults Fluoroquinolones also absorb well from the gut, reaching blood levels close to what an IV gives. Once a person is stable, able to swallow, and keeping food down, a pill can often do the work of a drip.

In lab tests, levofloxacin killed Pseudomonas somewhat better than ciprofloxacin.3PubMed Central. Effect of Ciprofloxacin, Levofloxacin, and Ofloxacin on Pseudomonas aeruginosa: A case control study with time kill curve analysis Another lab comparison found the two equal against some strains, with neither working against one, and the difference is unlikely to matter for patients.4PubMed Central. Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies At standard high doses, ciprofloxacin three times daily and levofloxacin 750 mg once daily each reached an ideal drug level in only about half of simulated cases.5PubMed. Simulated comparison of the pharmacodynamics of ciprofloxacin and levofloxacin against Pseudomonas aeruginosa using pharmacokinetic data from healthy volunteers and 2002 minimum inhibitory concentration data The choice often depends on which drug your lab report marks as working, since a strain can be reported as responding to one and not the other. Your other medicines count too: both drugs interact with some heart rhythm drugs and other medicines, so your prescriber needs your full list.

Day to day, ciprofloxacin is usually taken twice daily, sometimes three times for tougher infections. Levofloxacin is a single daily pill, which some people find easier to keep up. Your doctor sets the dose by infection site and kidney function.

Delafloxacin was about four times more potent than ciprofloxacin against Pseudomonas from skin and bone infections in lab testing.6PubMed Central. Comparative in vitro activity of Delafloxacin and other antimicrobials against isolates from patients with acute bacterial skin, skin-structure infection and osteomyelitis It also killed more multidrug-resistant Pseudomonas than cipro or levofloxacin in a lab model of cystic fibrosis mucus.7PubMed Central. Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant Pseudomonas aeruginosa in an In Vitro Cystic Fibrosis Sputum Model Overall, though, only about 65% of Pseudomonas strains respond to it, similar to the older drugs.8PubMed Central. Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic Properties A drug that works at lower amounts in a dish isn’t automatically better in your body. Delafloxacin is mainly approved for skin infections, so it is a less common pick.

Why Most Other Pills Don’t Work

Pseudomonas has an outer wall that lets little drug in, plus pumps that push antibiotics back out.9PubMed Central. β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects The bacterium can also form slimy films that shelter it from drugs.10PubMed Central. β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects Bacteria in that coating grow slowly and are harder to clear, particularly in wounds, bone, and damaged airways. Even a penicillin-type pill that binds its target well still fails to kill it.11PubMed Central. β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects

Fosfomycin concentrates in urine, which is why it works so well for common bladder infections caused by bacteria such as E. coli. Yet oral fosfomycin failed against Pseudomonas bladder infections in a lab model, even with high urine levels and daily doses for 7 days.12PubMed. Efficacy of single and multiple oral doses of fosfomycin against Pseudomonas aeruginosa urinary tract infections in a dynamic in vitro bladder infection model Most strains became resistant, and more so with longer treatment.13PubMed. Efficacy of single and multiple oral doses of fosfomycin against Pseudomonas aeruginosa urinary tract infections in a dynamic in vitro bladder infection model A fosfomycin sachet that cures a typical bladder infection isn’t a reliable choice when Pseudomonas is the cause. That is why your usual UTI antibiotic may be swapped. Common UTI pills like nitrofurantoin, amoxicillin and trimethoprim-sulfamethoxazole don’t cover Pseudomonas, so a culture naming it often means your doctor changes the prescription. It’s reasonable to ask whether the new drug matches the sensitivity report. Sometimes pills aren’t enough. If the lab shows resistance to the fluoroquinolones, IV or inhaled drugs may be the only options.

Reading Your Lab Result Before Taking the Pill

Labs grow your bacteria and test which drugs stop it, reporting each as S for susceptible (the drug works on your strain) or R for resistant (it doesn’t). Whether a strain counts as resistant depends on the cutoff the lab uses.14PubMed Central. Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance Under the stricter European standard, Pseudomonas ciprofloxacin resistance came out at 28% versus 10% under the US standard in one comparison.15PubMed Central. Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance

S means the drug is expected to work at a standard dose. R means it is not, so a drug marked R shouldn’t be chosen however convenient the pill is. I, for intermediate, is neither a pass nor a fail. It can mean the drug may work at a higher dose or where it concentrates well, such as in urine, and that is a decision for your prescriber. The report usually lists many drugs, and only some come as pills, so it helps to find the oral options on the list. Ask whether cipro or levofloxacin is marked S on your culture. Growing bacteria and testing drugs takes a couple of days. A doctor with a seriously ill patient often starts a drug that is likely to work and adjusts once the report returns. Tell your doctor if you took a fluoroquinolone recently. Recent exposure raises the chance your strain is already resistant.

Why Pseudomonas Can Become Resistant During Treatment

In early experience with oral ciprofloxacin, Pseudomonas became resistant in 25 of 96 infections.16PubMed. Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa This happens most where bacteria are numerous or the drug reaches tissue poorly.17PubMed. Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches Resistance doesn’t always mean the treatment fails.18PubMed. Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches If you are improving, the doctor may keep going with the pill. A repeat culture showing resistance means the bacteria have changed, which may call for a different drug, but your doctor weighs that against how you feel.

The main route is a change in the bacterial enzyme the drug attacks.19PubMed. Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa Extra changes that ramp up the bacteria’s drug pumps add to it.20PubMed Central. Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa A combination of both can raise resistance far more than either alone.21PubMed Central. Targeting efflux pumps prevents the multi-step evolution of high-level resistance to fluoroquinolone in Pseudomonas aeruginosa

Among hospital patients, lung Pseudomonas became cipro-resistant more often (12%) than at other sites (4%).22Infection Control & Hospital Epidemiology. Pharmacodynamic Modeling of Risk Factors for Ciprofloxacin Resistance in Pseudomonas aeruginosa Lung infections treated with low cipro exposure had the highest resistance, 17%.23Infection Control & Hospital Epidemiology. Pharmacodynamic Modeling of Risk Factors for Ciprofloxacin Resistance in Pseudomonas aeruginosa Low drug levels give partly resistant bacteria room to win.24PubMed Central. Fluoroquinolone resistance in ESKAPE pathogens: evolutionary pathways, one health transmission, and clinical surveillance In lab testing, short high-concentration exposure caused no resistance, while steady lower exposure over 24 hours let resistant bacteria take over.25PubMed. Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosa That is why dose and timing matter more for lung infections than for ones where the drug is concentrated, such as the bladder. To lower the risk, take every dose on schedule and finish the course. Don’t split pills or save some for later, and don’t keep leftover cipro for future infections.

Fever or pain that returns after early improvement, or discharge or cough that worsens, may mean the drug is failing. Report it promptly, because a repeat culture can check for resistance.

Food, Supplements, and Tube Feeds That Block Absorption

Products containing magnesium, aluminum or calcium reduce how much ciprofloxacin your body absorbs.26PubMed Central. Clinical Equivalency of Ciprofloxacin 750 mg Enterally and 400 mg Intravenously for Patients Receiving Enteral Feeding: Systematic Review These minerals, along with iron, bind to the drug in the gut and form a complex the body can’t absorb, so the pill passes through with less of it entering the blood. Tube or liquid feeds lowered cipro absorption by 27% to 67% in hospital patients.27PubMed Central. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes.

The effect depends on timing, so the same pill taken apart from these products can work well. Leaflets typically advise taking cipro 2 hours before or 6 hours after them. Antacids for heartburn, calcium and iron supplements, calcium-fortified juice, and multivitamins with minerals are the usual culprits, and many people overlook them. Milk or yogurt taken alone with the pill can also reduce absorption, though a normal meal that includes some dairy is a smaller concern. A pharmacist can check your full supplement list. If you are fed by tube, doctors often pause feeds around doses or use higher doses. Some patients need IV dosing instead.

How Well Pills Work for Bone, Lung, and Other Infections

Oral ciprofloxacin plus surgical cleaning cured 19 of 20 patients with Pseudomonas bone infection.28PubMed Central. Oral ciprofloxacin treatment of Pseudomonas aeruginosa osteomyelitis In a larger group of 67 patients treated with surgery and antibiotics, about 79% were cured.29PubMed Central. A Review of the Clinical Utilization of Oral Antibacterial Therapy in the Treatment of Bone Infections in Adults Infected or dead bone has a poor blood supply, so antibiotics can’t reach it well, and those cure rates came from surgery and antibiotics together, not pills alone. One approach uses up to 15 days of IV antibiotics, then an oral fluoroquinolone for up to six weeks total.30PubMed Central. A Review of the Clinical Utilization of Oral Antibacterial Therapy in the Treatment of Bone Infections in Adults The course is long because bone clears slowly, and stopping early can let the infection return. Your team may check blood tests and symptoms along the way to see whether it is settling. Many patients start in hospital on IV drugs, then go home on cipro. The switch usually follows clear improvement: someone who is stable, eating and keeping pills down can often continue at home.

In bronchiectasis, meaning widened, scarred airways, adding inhaled tobramycin to cipro cleared more bacteria but didn’t improve symptoms more than cipro alone.31PubMed. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis A bigger drop in bacteria doesn’t always mean you feel better, so your doctor weighs the benefit against the added burden of an inhaler treatment. In children with cystic fibrosis, oral cipro worked about as well as standard IV combinations for flare-ups.32PubMed. Safety and efficacy of ciprofloxacin in paediatric patients–review

Side Effects, Including in Children

Children on ciprofloxacin had side effects in 5% to 15% of cases, mostly stomach, skin, and nervous system reactions.33PubMed. Safety and efficacy of ciprofloxacin in paediatric patients–review About 1 in 62 children had a muscle or joint problem, most often knee pain.34Clinical and Experimental Pediatrics. Systemic use of fluoroquinolone in children That figure covers muscle and joint problems of any kind, not only serious ones. These resolved after stopping the drug, with no lasting damage seen.35Clinical and Experimental Pediatrics. Systemic use of fluoroquinolone in children Limping or new knee pain should be reported. Stomach upset is common and usually mild.

Fluoroquinolones were once avoided in children because of cartilage damage in young animals, so doctors now reserve them for when the benefit is clear. Cystic fibrosis is the classic case, because Pseudomonas lung infections recur and the alternatives often require IV drugs.

In adults, fluoroquinolones carry warnings for tendon pain and rupture. The risk is highest in older adults, people on steroid medicines, and transplant recipients. The Achilles tendon at the back of the ankle is the most common site, so heel or calf pain deserves attention. If you feel sudden pain or swelling in a tendon or joint, stop the drug and call your doctor the same day, since continued use can lead to rupture. Rest the area until you are told otherwise, because exercise can worsen a damaged tendon.

What’s Coming Next

A new IV combination, cefepime with taniborbactam, restores activity against highly resistant Pseudomonas and is in late-stage trials.36PubMed. What Is New in the Anti–Pseudomonas aeruginosa Clinical Development Pipeline Since the 2017 WHO Alert? It is aimed at strains that resist nearly everything and is intended for hospital use. Because it is given by drip, it doesn’t help someone hoping to go home on a pill.

Protecting the current pills by using them carefully matters.37PubMed. Current choices of antibiotic treatment for Pseudomonas aeruginosa infections Using cipro only when cultures support it helps keep it working for your next infection. If Pseudomonas turns up without symptoms, it’s fair to ask whether an antibiotic is truly needed.